Big Pharma Split Corp.

Distributions

(For the purposes of the Income Tax Act (Canada) and any corresponding provincial or territorial legislation, all dividends paid by Big Pharma Split Corp. on its Class A Shares and Preferred Shares are “eligible dividends”, unless otherwise indicated.)

Last Distribution Per Unit
(Class A)
:
$0.1031
Last Ex-dividend Date
(Class A)
:
2021/07/29
Last Record Date
(Class A)
:
2021/07/30
Distribution Frequency
(Class A)
:
Monthly
Distributions Since Inception*
(Class A)
:
$5.2524
Last Distribution Per Unit
(Preferred Share)
:
$0.1250
Last Ex-dividend Date
(Preferred Share)
:
2021/06/29
Last Record Date
(Preferred Share)
:
2021/06/30
Distribution Frequency
(Preferred Share)
:
Quarterly
Distributions Since Inception*
(Preferred Share)
:
$1.8016
Ex-dividend DateRecord DateClass A ShareDistribution FrequencyPreferred ShareDistribution Frequency
2021/07/292021/07/30$0.1031Monthly-
2021/06/292021/06/30$0.1031Monthly$0.1250Quarterly
2021/05/282021/05/31$0.1031Monthly-
2021/04/292021/04/30$0.1031Monthly-
2021/03/302021/03/31$0.1031Monthly$0.1250Quarterly
2021/02/252021/02/26$0.7160Special-
2021/02/252021/02/26$0.1031Monthly-
2021/01/282021/01/29$0.1031Monthly-
Ex-dividend DateRecord DateClass A ShareDistribution FrequencyPreferred ShareDistribution Frequency
2020/12/302020/12/31$0.1031Monthly$0.1250Quarterly
2020/11/272020/11/30$0.1031Monthly-
2020/10/292020/10/30$0.1031Monthly-
2020/09/292020/09/30$0.1031Monthly$0.1250Quarterly
2020/08/282020/08/31$0.1031Monthly-
2020/07/302020/07/31$0.1031Monthly-
2020/06/292020/06/30$0.1031Monthly$0.1250Quarterly
2020/05/282020/05/29$0.1031Monthly-
2020/04/292020/04/30$0.1031Monthly-
2020/03/302020/03/31$0.1031Monthly$0.1250Quarterly
2020/02/272020/02/28$0.1031Monthly-
2020/01/302020/01/31$0.1031Monthly-
Ex-dividend DateRecord DateClass A ShareDistribution FrequencyPreferred ShareDistribution Frequency
2019/12/302019/12/31$0.1031Monthly$0.1250Quarterly
2019/11/282019/11/29$0.1031Monthly-
2019/10/302019/10/31$0.1031Monthly-
2019/09/272019/09/30$0.1031Monthly$0.1250Quarterly
2019/08/292019/08/30$0.1031Monthly-
2019/07/302019/07/31$0.1031Monthly-
2019/06/272019/06/28$0.1031Monthly$0.1250Quarterly
2019/05/302019/05/31$0.1031Monthly-
2019/04/292019/04/30$0.1031Monthly-
2019/03/282019/03/29$0.1031Monthly$0.1250Quarterly
2019/02/272019/02/28$0.1031Monthly-
2019/01/302019/01/31$0.1031Monthly-
Ex-dividend DateRecord DateClass A ShareDistribution FrequencyPreferred ShareDistribution Frequency
2018/12/282018/12/31$0.1031Monthly$0.1250Quarterly
2018/11/292018/11/30$0.1031Monthly-
2018/10/302018/10/31$0.1031Monthly-
2018/09/272018/09/28$0.1031Monthly$0.1250Quarterly
2018/08/302018/08/31$0.1031Monthly-
2018/07/302018/07/31$0.1031Monthly-
2018/06/282018/06/29$0.1031Monthly$0.1250Quarterly
2018/05/302018/05/31$0.1031Monthly-
2018/04/272018/04/30$0.1031Monthly-
2018/03/282018/03/29$0.1031Monthly$0.1250Quarterly
2018/02/272018/02/28$0.1031Monthly-
2018/01/302018/01/31$0.1031Monthly-
Ex-dividend DateRecord DateClass A ShareDistribution FrequencyPreferred ShareDistribution Frequency
2017/12/282017/12/29$0.1031Monthly$0.0516Quarterly

* Since Inception Date:  Class A is 2017/11/24;  Preferred Share is 2017/11/24.

2021

Date Symbol NAV $ Distribution Total $

(Since Inception)

2021-07-30PRM15.005.252
2021-07-30PRM.PR.A10.001.802

Why Invest In This Fund?


Big Pharma Split Corp. will invest in an initially equally-weighted portfolio comprised of Equity Securities of ten issuers, selected by the Portfolio Manager from the Investable Universe, that at the time of investment and immediately following each semi-annual reconstitution and rebalancing: (i) are listed on a North American exchange; (ii) pay a dividend; and (iii) have options in respect of its Equity Securities that, in the opinion of the Portfolio Manager, are sufficiently liquid to permit the Portfolio Manager to write options in respect of such securities. The Portfolio will be comprised primarily of the largest (as determined by market capitalization calculated in US$) Pharmaceutical Issuers in the Investable Universe.

The Manager will hedge substantially all of the Portfolio’s U.S dollar exposure back to the Canadian dollar.

The Class A Shares provide holders a monthly cash distribution and are targeted to be $0.1031 per share and, for the Preferred Shares, quarterly cash distributions are fixed at $0.1250 per share.

Fund Quick Facts

June 30, 2021
TSX Code PRM  | PRM.PR.A
Cusip PRM 08934P108
Cusip PRM.PR.A 08934P207
Total AUM $32.6 million
Management Fee 0.75%
Number of Equity Securities 10
Income Distribution PRM Monthly
Income Distribution PRM.PR.A Quarterly
Distribution PRM $0.1031
Distribution PRM.PR.A $0.1250
Current Yield – PRM 8.66%
Distribution Method Cash
RSP Eligible RRSP/RRIF/RESP/TFSA
 

Portfolio Analysis*


Average Market Capitalization (CAD) 258B
Average Dividend Yield 3.22%
Average P/E 15.7x

Investor Documents

Monthly Summary  Eng


Quarterly Summary  Eng


Prospectus Eng | Fr

Portfolio Management

 

 

PAUL MACDONALD, CFAChief Investment Officer

JAMES LEARMONTH, CFASenior Portfolio Manager
MIKE
DRAGOSITS
, CFA
Portfolio Manager

Historical Prices

Portfolio Holdings

As at June 30, 2021


NameTickerWeightSectorCountry
Eli Lilly and CompanyLLY US11.1%PharmaceuticalsUnited States
AstraZeneca PLCAZN US10.7%PharmaceuticalsUnited States
Merck & Co., Inc.MRK US10.0%PharmaceuticalsUnited States
Bristol-Myers Squibb CompanyBMY US9.9%PharmaceuticalsUnited States
AbbVie Inc.ABBV US9.8%BiotechnologyUnited States
Amgen Inc.AMGN US9.8%BiotechnologyUnited States
Johnson & JohnsonJNJ US9.8%PharmaceuticalsUnited States
Pfizer Inc.PFE US9.8%PharmaceuticalsUnited States
Sanofi S.A.SNY US9.8%PharmaceuticalsUnited States
Novartis AGNVS US9.6%PharmaceuticalsUnited States
Cash and other assets and liabilities1.7%
Market value of options(0.4)%
Foreign currency forwards(1.7)%

Download CSV

Sub-Sector Allocation

As at June 30, 2021

Cumulative Growth $10,000 Invested

 (NAV pricing)


Disclaimer

The information contained herein is not an offer to sell nor a solicitation to buy the aforementioned security. You will usually pay brokerage fees to your investment dealer if you purchase or sell Class A shares or Preferred shares of Big Pharma Split Corp. (the “Fund”) on the TSX. If shares are purchased or sold on the TSX, investors may pay more than the current net asset value when buying shares of the Fund and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning shares of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account income taxes payable by any securityholder that would have reduced returns. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash from the Class A shares or Preferred shares of the Fund. If the Fund earns less than the amount distributed, the difference is a return of capital. The current yield is calculated based on the market price of the Fund. Big Pharma Split Corp. is managed by Harvest Portfolios Group Inc.

**Filed on SEDAR April 01, 2020 per NI 81-503 Extension of Certain Filing, Delivery and Prospectus Renewal Requirements of Investment Funds.

† The first year of Calendar Year Performance presents the rate of return from commencement of operations to December 31 of that year.

 

Subscribe to Our Newsletter and Stay Informed

Subscribe Now

Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *


Join Us & Stay Informed!

* indicates required

Your Preferences   (Please select all the ways you would like to hear from)


You are a *


Confirm *